by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
ATLANTA, Sept. 14, 2016 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced its financial results for the fourth quarter and 2016 fiscal year ended June 30, 2016, and also provided an update on recent corporate and clinical developments....
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
WALTHAM, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to niraparib for the treatment of...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
ATLANTA, Sept. 06, 2016 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR) (formerly Biota Pharmaceuticals, Inc.), a pharmaceutical company that is developing the next generation of antivirals, announced today that the Company has granted two new hires...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
BERKELEY HEIGHTS, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) — Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced additional positive pharmacokinetic data from the Phase 1/2 NEWTON (Nimodipine microparticles to Enhance recovery While reducing TOxicity after...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
PRINCETON, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’Connor, president and chief executive officer of Advaxis, will present a...